glp-1 agonists tirzepatide How Does Work? The dual agonist action of

For similar supplements to support your metabolic health and weight management journey, check out GLP-1 Supplements and Nutrition.*

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

While peptide drugs have a wide range of therapeutic applications, their relatively short half-life has been a challenge, attributed to poor metabolic stability and a fluid dynamic radius below the glomerular filtration limit of the kidneys.

Tirzepatide, the first dual GIP/GLP-1 receptor co-agonist approved for type 2 diabetes in the USA, Europe, and the UAE, targets both appetite and glucose control

Nausea is one of the most common side effects of GLP-1 medications

Lose weight & control blood sugar